Tridihexethylchlorid

TRIDIHEXETHYL CHLORIDE (200 MG) Struktur
4310-35-4
CAS-Nr.
4310-35-4
Bezeichnung:
Tridihexethylchlorid
Englisch Name:
TRIDIHEXETHYL CHLORIDE (200 MG)
Synonyma:
Pathilon;tridihexethyl chloride;Propethonum;pathilonchloride;XJGONMZLEDGBRM-UHFFFAOYSA-N;TRIDIHEXETHYL CHLORIDE (200 MG);Tridihexethyl Chloride (1683005);(3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethylammoniumchloride;(3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethyl-ammoniuchloride;gamma-cyclohexyl-n,n,n-triethyl-gamma-hydroxy-benzenepropanaminiuchlorid
CBNumber:
CB3501412
Summenformel:
C21H35ClNO
Molgewicht:
352.9617
MOL-Datei:
4310-35-4.mol

Tridihexethylchlorid Eigenschaften

Aggregatzustand
Solid
Farbe
White to off-white

Sicherheit

Tridihexethylchlorid Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Tridihexethyl Chloride, is an anticholinergic, antimuscarinic and antispasmodic drug.

Allgemeine Beschreibung

Tridihexethyl chloride,3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethylammoniumchloride (Pathilon), is a white, bitter, crystalline powderwith a characteristic odor. The compound is freely soluble inwater and alcohol, with aqueous solutions being nearly neutralin reaction.
Although this drug, introduced in 1958, has ganglionblockingactivity, its peripheral atropine-like activity predominates;therefore, its therapeutic application has beenbased on the latter activity. It possesses the antispasmodicand the antisecretory activities characteristic of this group,but because of its quaternary character, it is valueless in relievingParkinson syndrome.

Clinical Use

tridihexethyl chloride is useful for adjunctive therapy in a wide varietyof GI diseases, such as peptic ulcer, gastric hyperacidity,and hypermotility and spastic conditions, such as spasticcolon, functional diarrhea, pylorospasm, and other relatedconditions. Because its action is predominantly antisecretory,it is more effective in gastric hypersecretion than in hypermotilityand spasm. It is best administered intravenouslyfor the latter conditions.
The side effects usually found with effective anticholinergictherapy occur with the use of this drug. These are drynessof mouth, mydriasis, and such. As with other anticholinergics,care should be exercised when administering the drug topatients with glaucomatous conditions, cardiac decompensation,and coronary insufficiency. It is contraindicated inpatients with obstruction at the bladder neck, prostatic hypertrophy,stenosing gastric and duodenal ulcers, or pyloric orduodenal obstruction.

Tridihexethylchlorid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Tridihexethylchlorid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 96815 76
Sinopharm Chemical Reagent Co,Ltd. 86-21-63210123
sj_scrc@sinopharm.com China 9823 79
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 13028896684
sales@rrkchem.com China 56070 58
Changzhou Bojia Biomedical Technology Co., Ltd. 2122619822
czbjpharma@126.com China 18488 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 23963 58

4310-35-4(Tridihexethylchlorid)Verwandte Suche:


  • TRIDIHEXETHYL CHLORIDE (200 MG)
  • (3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethyl-ammoniuchloride
  • (3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethylammoniumchloride
  • gamma-cyclohexyl-n,n,n-triethyl-gamma-hydroxy-benzenepropanaminiuchlorid
  • pathilonchloride
  • XJGONMZLEDGBRM-UHFFFAOYSA-N
  • Tridihexethyl Chloride (1683005)
  • Propethonum
  • Pathilon
  • tridihexethyl chloride
  • 4310-35-4
  • C21H36NOCl
Copyright 2019 © ChemicalBook. All rights reserved